A growing body of clinical studies has shown that TLR4 expression and activation are increased in patients with viral hepatitis-induced HCC [86,87] and that elevated serum levels of soluble TLR4 may be a useful biomarker for HCC detection and monitoring [88]. Here, TLR4 is linked to hepatocellular carcinoma.